The effects of in vitro hemodilution with 6% hydroxyethyl starch (HES) (130/0.4) solution on thrombelastograph analysis in patients undergoing liver transplantation

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages 450-456

  Bang, Si Ra ^a   Kim, Yoon Hee ^b   Kim, Gaab Soo ^c  

^a Inje University College of Medicine   (South Korea)

^b Chungnam National University College of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

6 HES 130 0.4 (hydroxyethyl starch) solution; End stage liver disease; Hemodilution; Liver transplantation; Thrombelastograph

Indexed keywords

ANTITHROMBIN III; DILUENT; FIBRINOGEN; HETASTARCH; SODIUM CHLORIDE;

ADULT; AMPLITUDE MODULATION; ARTICLE; AUTOANALYZER; BLOOD ANALYSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TIME; BLOOD SAMPLING; CONTROLLED STUDY; END STAGE LIVER DISEASE; FEMALE; HEMODILUTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REACTION TIME; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

BLOOD COAGULATION; END STAGE LIVER DISEASE; FEMALE; HEMODILUTION; HETASTARCH; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; SODIUM CHLORIDE; THROMBELASTOGRAPHY; WHOLE BLOOD COAGULATION TIME;

EID: 79958762999     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01294.x     Document Type: Article

References (29)

1. Marietta M, Facchini L, Pedrazzi P, Busani S, Torelli G. Pathophysiology of bleeding in surgery. Transplant Proc 2006: 38: 812.
2. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998: 87: 989.
3. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001: 92: 855.
4. Haisch G, Boldt J, Krebs C, Kumle B, Suttner S, Schulz A. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesth Analg 2001: 92: 565.
5. Conroy JM, Fishman RL, Reeves ST, Pinosky ML, Lazarchick J. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII:C. Anesth Analg 1996: 83: 804.
6. Trotter JF. Coagulation abnormalities in patients who have liver disease. Clin Liver Dis 2006: 10: 665.
7. Srinivasa V, Gilbertson LI, Bhavani-Shankar K. Thromboelastography: where is it and where is it heading? Int Anesthesiol Clin 2001: 39: 35.
8. Petroianu GA, Liu J, Maleck WH, Mattinger C, Bergler WF. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on thrombelastograph. Anesth Analg 2000: 90: 795.
9. Ekseth K, Abildgaard L, Vegfors M, Berg-Johnsen J, Engdahl O. The in vitro effects of crystalloids and colloids on coagulation. Anaesthesia 2002: 57: 1102.
10. Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005: 49: 373.
11. Entholzner EK, Mielke LL, Calatzis AN, Feyh J, Hipp R, Hargasser SR. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiol Scand 2000: 44: 1116.
12. Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996: 76: 412.
13. Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998: 80: 612.
14. Roche AM, James MF, Bennett-Guerrero E, Mythen MG. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesth Analg 2006: 102: 1274.
15. Amitrano L, Guardascione MA, Brancaccio V, Balzano A. Coagulation disorders in liver disease. Semin Liver Dis 2002: 22: 83.
16. Di Benedetto P, Baciarello M, Cabetti L, Martucci M, Chiaschi A, Bertini L. Thrombelastography. Present and future perspectives in clinical practice. Minerva Anestesiol 2003: 69: 501.
17. Lai FO, Lee TL, Kumar A. Intraoperative anaesthetic management of the liver transplant patient. Ann Acad Med Singapore 1991: 20: 458.
18. Rapaport SI. Coagulation problems in liver disease. Blood Coagul Fibrinolysis 2000: 11(Suppl 1): S69.
19. Ng KF, Lam CC, Chan LC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002: 88: 475.
20. Ruttmann TG, Jamest MF, Lombard EH. Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care 2001: 29: 489.
21. Nielsen VG, Lyerly RT III, Gurley WQ. The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activation. Anesth Analg 2004: 99: 1587.
22. Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006: 12: 7725.
23. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999: 25: 258.
24. Collis RE, Collins PW, Gutteridge CN et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994: 20: 37.
25. Niemi TT, Kuitunen AH. Hydroxyethyl starch impairs in vitro coagulation. Acta Anaesthesiol Scand 1998: 42: 1104.
26. Boldt J, Suttner S, Brosch C, Lehmann A, Mengistu A. Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery. Br J Anaesth 2009: 102: 191.
27. Plotkin AJ, Wade CE, Jenkins DH et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008: 64: S64.
28. De Lorenzo C, Calatzis A, Welsch U, Heindl B. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%. Anesth Analg 2006: 102: 1194.
29. Osthaus WA, Witt L, Johanning K et al. Equal effects of gelatin and hydroxyethylstarch (6% HES 130/0.42) on modified thrombelastography in children. Acta Anaesthesiol Scand 2009: 53: 305.